Compound details
Nornicotine
| Compound ID | CDAMM02067 |
|---|---|
| Common name | Nornicotine | IUPAC name | 3-pyrrolidin-2-ylpyridine |
| Molecular formula | C9H12N2 |
| Retention time | 7.64 |
|---|---|
| Adduct | [2M+H]+ |
| Actual mz | 297.206 | Theoretical mz | 297.207 |
| Error | 2.95 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 5.4746 |
| Inchi key | MYKUKUCHPMASKF-UHFFFAOYNA-N |
|---|---|
| Smiles | N=1C=CC=C(C1)C2NCCC2 |
| Superclass | Organoheterocyclic compounds |
| Class | Pyridines and derivatives |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| P43681 | CHRNA4 | Neuronal acetylcholine receptor; alpha4/beta2 | T70967 | SwissTargetPrediction and SEA |
| P36544 | CHRNA7 | Neuronal acetylcholine receptor protein alpha-7 subunit | T34429 | SwissTargetPrediction and SEA |
| P32297 | CHRNA3 | Neuronal acetylcholine receptor; alpha3/beta4 | T74166 | SwissTargetPrediction and SEA |
| P11509 | CYP2A6 | Cytochrome P450 2A6 | T06455 | SEA |
| P55786 | NPEPPS | Puromycin-sensitive aminopeptidase | T15610 | SEA |
| P30926 | CHRNB4 | Neuronal acetylcholine receptor; alpha2/beta4 | T73724 | SwissTargetPrediction and SEA |
| Q15822 | CHRNA2 | Neuronal acetylcholine receptor; alpha2/beta2 | T55815 | SwissTargetPrediction |
| P17787 | CHRNB2 | Nicotinic acetylcholine receptor alpha2/beta2 | T82543 | SEA |
| P20813 | CYP2B6 | Cytochrome P450 2B6 | T11793 | SEA |
| Q9UMJ8 | GBA1 | Lysosomal acid glucosylceramidase | T63243 | SEA |
| P02708 | CHRNA1 | Neuronal acetylcholine receptor alpha-1 | T04689 | SEA |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T70967 | DI0029 | Aneurysm/dissection | [ICD-11: BD50] | P43681 | CHRNA4 |
| T70967 | DI0191 | Hypertensive crisis | [ICD-11: BA03] | P43681 | CHRNA4 |
| T70967 | DI0196 | Hypotension | [ICD-11: BA20-BA21] | P43681 | CHRNA4 |
| T34429 | DI0101 | Corneal disease | [ICD-11: 9A76-9A78] | P36544 | CHRNA7 |
| T34429 | DI0370 | Schizophrenia | [ICD-11: 6A20] | P36544 | CHRNA7 |
| T74166 | DI0105 | Cough | [ICD-11: MD12] | P32297 | CHRNA3 |
| T06455 | DI0283 | Mycosis fungoides | [ICD-11: 2B01] | P11509 | CYP2A6 |
| T06455 | DI0351 | Psoriasis | [ICD-11: EA90] | P11509 | CYP2A6 |
| T15610 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P55786 | NPEPPS |
| T15610 | DI0284 | Myelodysplastic syndrome | [ICD-11: 2A37] | P55786 | NPEPPS |
| T73724 | DI0301 | Nicotine use disorder | [ICD-11: 6C4A] | P30926 | CHRNB4 |
| T55815 | DI0101 | Corneal disease | [ICD-11: 9A76-9A78] | Q15822 | CHRNA2 |
| T55815 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | Q15822 | CHRNA2 |
| T55815 | DI0166 | Glaucoma | [ICD-11: 9C61] | Q15822 | CHRNA2 |
| T55815 | DI0301 | Nicotine use disorder | [ICD-11: 6C4A] | Q15822 | CHRNA2 |
| T55815 | DI0411 | Tonus and reflex abnormality | [ICD-11: MB47] | Q15822 | CHRNA2 |
| T82543 | DI0301 | Nicotine use disorder | [ICD-11: 6C4A] | P17787 | CHRNB2 |
| T63243 | DI0242 | Lysosomal disease | [ICD-11: 5C56] | Q9UMJ8 | GBA1 |
| T04689 | DI0411 | Tonus and reflex abnormality | [ICD-11: MB47] | P02708 | CHRNA1 |